Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functions
While efficient at treating B-cell malignancies, Bruton tyrosine kinase (BTK) inhibitors are consistently reported to increase the risk of bleeding. Analyzing platelet aggregation response to collagen in platelet-rich plasma allowed us to identify two groups in the healthy population characterized b...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Ferrata Storti Foundation
2019-11-01
|
| Serie: | Haematologica |
| Accesso online: | https://haematologica.org/article/view/9132 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|